Position in ABEO
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$13,888,000
+$3,348,000 QoQ
Shares Held
3,100,000
+55.0% QoQ
Ownership
5.44%
of shares outstanding
% of Portfolio
2.84%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 73%
Shared 27%
None 0%
Common Shares in ABEO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AIGH Capital Management LLC holds $126,310,878 across 15 Biotechnology names. ABEO ranks #3 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VNDA |
Vanda Pharmaceuticals Inc.
|
2,750,000 | $19,002,499 | |
| 2 | KYTX |
Kyverna Therapeutics, Inc.
|
2,000,000 | $17,259,999 | |
| 3 | ABEO |
Abeona Therapeutics Inc.
This page
|
3,100,000 | $13,888,000 | |
| 4 | LRMR |
Larimar Therapeutics, Inc.
|
3,000,000 | $13,499,999 | |
| 5 | FENC |
Fennec Pharmaceuticals Inc.
|
1,981,501 | $12,186,230 | |
| 6 | ZVRA |
Zevra Therapeutics, Inc.
|
1,200,000 | $11,183,999 | |
| 7 | VSTM |
Verastem, Inc.
|
2,000,000 | $10,599,999 | |
| 8 | TARA |
Protara Therapeutics, Inc.
|
1,622,733 | $8,454,438 |
All Filings in ABEO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,888,000 | 3,100,000 | Shares | Other | 2026-04-30 | |
| 2025-12-31 | $10,540,000 | 2,000,000 | Shares | Other | 2026-02-02 | |
| 2023-12-31 | $3,946,722 | 787,769 | Shares | Other | 2024-02-12 | |
| 2023-09-30 | $4,779,410 | 1,135,252 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $2,575,064 | 638,974 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $1,839,130 | 652,174 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $2,008,695 | 652,174 | Shares | Other | 2023-02-15 | |
| 2022-09-30 | $427,556 | 140,644 | Shares | Other | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||